Mar 01, 2021 / 02:10PM GMT
Andrew Harris Cooper - Raymond James & Associates, Inc., Research Division - Senior Research Associate
Sorry about that. Good morning, everyone. Welcome to the Raymond James Institutional Investor Conference. Thanks for joining us. I'm Andrew Cooper, and I cover animal health here for Raymond James. And we're excited to have IDEXX joining us this morning for a fireside chat.
Just some quick housekeeping. I'd love to include some questions from the audience today. (Operator Instructions)
Like I said, excited to have IDEXX, it's the largest player and, really, the leader in pretty much any sense of the word in animal diagnostics, which is one of the fastest-growing spaces in a really terrific end market.
With that, we have CEO, Jay Mazelsky here; as well as CFO, Brian McKeon. And Director of IR, John Ravis. And I'm going to jump right into some Q&A here.
Questions and Answers:
Andrew Harris Cooper - Raymond James & Associates, Inc., Research Division - Senior Research AssociateMaybe just to start with some high